TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
KURA

Kura Oncology Inc

Healthcare · Biotechnology

11.70$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Kura Oncology Inc (KURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 67 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KURA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54 67
0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.8 0.8 0.8 0.1
0.0 0.0 0.0 0.0 0.0 -0.2 -0.6 -0.8 -0.8 54 67
8.0 18 20 26 47 48 60 85 93 115 170 251
3.8 6.1 8.0 9.7 16 20 31 47 47 51 77 120
11 24 28 36 63 67 92 131 140 165 247 371
-12 -24 -28 -36 -63 -67 -92 -131 -140 -166 -193 -304
0.0 0.1 0.6 0.9 1.0 0.6 0.6 0.4 0.2 1.5 1.6 1.5
-11 -23 -28 -35 -60 -63 -90 -130 -136 -153 -172 -278
0.3 0.0 0.0 0.0 3.4 -4.9 -0.2 -0.6 0.2 2.0 0.3
-11 -23 -28 -35 -60 -63 -90 -130 -136 -153 -174 -279
-12 -24 -28 -36 -63 -67 -89 -129 -135 -150 -169 -276

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?